Loading provider…
Loading provider…
Gastroenterology Physician in Orlando, FL
NPI: 1225227507Primary Practice Location
ORLANDO HEALTH-HEALTH CENTRAL HOSPITAL
10000 W Colonial Dr, Ocoee, FL
Primary Employer
Orlando Health Medical Group Inc
orlandohealth.com
HQ Phone
Get MD Udayakumar's Phone Numberphone_androidMobile
Get MD Udayakumar's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
FL State Medical License
FL State Medical License
2014 - 2026
OH State Medical License
2007 - 2016

American Board of Internal Medicine
Gastroenterology
Cleveland Clinic Foundation
Fellowship • Advanced Endoscopy
2013 - 2014
Fellowship • Gastroenterology
2010 - 2013
University of Cincinnati Medical Center/College of Medicine
Residency • Internal Medicine
2007 - 2010
Madurai Medical College
Medical School
Until 2003
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 109 | 201 |
| 2 | 45380Biopsy of the large bowel using an endoscope (colonoscopy) | 98 | 110 |
| 3 | 45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 84 | 91 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 46 | 46 |
| 5 | 45390Removal of large bowel tissue using an endoscope | 34 | 39 |
Authors: Ji Young Bang, Shyam Varadarajulu, Muhammad Hasan, Robert Hawes
Journal: Gastrointest Endosc
Publication Date: 2016-04-02
Intraductal papillary mucinous neoplasm and acute pancreatitis.
Authors: Santhi Vege
Journal: World J Gastrointest Oncol
Impact of Clostridium difficile infection in patients with ulcerative colitis
Lead Sponsor: The Cleveland Clinic
Intervention / Treatment: OTHER: Sample Collection
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Mirikizumab
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Mirikizumab, DRUG: Ustekinumab